Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kito

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 1, 1994
[Rotarod method in young rats and the antidepressive effect: is the rotarod method capable of evaluating antidepressive effects?]S Morimoto, G Kito
Japanese Journal of Pharmacology|August 1, 1989
Effects of CV-3611, a new free radical scavenger, on ischemic heart failure in conscious beagle dogsM Tanabe, G Kito
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 1, 1995
Effects of the non-peptide angiotensin II receptor antagonist TCV-116 on systemic and renal hemodynamics in dogs with renal hypertensionK Ito, M Shiomi, G Kito
Arzneimittel-Forschung|July 1, 1996
General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl] methyl]-1 H-benzimidazole-7-carboxylate. Part II: Effect on cardiovascular system and renal functionsG Kito, K Ito, M Shiomi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 1, 1993
[Effect of CV-4151 on the cerebral hypoperfusion and production of thromboxane A2 following complete cerebral ischemia-reperfusion in dogs]G Kito, M Tanabe, Z Terashita
Arzneimittel-Forschung|June 1, 1996
General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other propertiesG Kito, S Morimoto, M Shiomi
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1997
Characterization of the high sensitivity of rabbits to the effects of TCV-116, an angiotensin II receptor antagonistK Sato, F Chatani, K Ito, et al.
Brain Research|July 23, 1984
Influence of cerebral cortex stimulation upon cough-like spasmodic expiratory response (SER) and cough in the catY Kasé, G Kito, T Miyata, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1977
Neural mechanism for production of spasmodic expiratory response like cough induced by amygdala stimulation in the cat. I. Pathways from the amygdala to the lower brain stemG Kito, Y Kasé, T Miyata, et al.
European Journal of Pharmacology|June 17, 1986
The antiobesity action of (S)-(+)-1-(4-chlorophenylthiomethyl)-N-methylethylamine fumarate (AO-124)H Ikeda, K Shimakawa, G Kito, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|July 1, 1994
[Rotarod method in young rats and the antidepressive effect: is the rotarod method capable of evaluating antidepressive effects?]S Morimoto, G Kito
Japanese Journal of Pharmacology|August 1, 1989
Effects of CV-3611, a new free radical scavenger, on ischemic heart failure in conscious beagle dogsM Tanabe, G Kito
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 1, 1995
Effects of the non-peptide angiotensin II receptor antagonist TCV-116 on systemic and renal hemodynamics in dogs with renal hypertensionK Ito, M Shiomi, G Kito
Arzneimittel-Forschung|July 1, 1996
General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy) ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl] methyl]-1 H-benzimidazole-7-carboxylate. Part II: Effect on cardiovascular system and renal functionsG Kito, K Ito, M Shiomi
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 1, 1993
[Effect of CV-4151 on the cerebral hypoperfusion and production of thromboxane A2 following complete cerebral ischemia-reperfusion in dogs]G Kito, M Tanabe, Z Terashita
Arzneimittel-Forschung|June 1, 1996
General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other propertiesG Kito, S Morimoto, M Shiomi
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1997
Characterization of the high sensitivity of rabbits to the effects of TCV-116, an angiotensin II receptor antagonistK Sato, F Chatani, K Ito, et al.
Brain Research|July 23, 1984
Influence of cerebral cortex stimulation upon cough-like spasmodic expiratory response (SER) and cough in the catY Kasé, G Kito, T Miyata, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1977
Neural mechanism for production of spasmodic expiratory response like cough induced by amygdala stimulation in the cat. I. Pathways from the amygdala to the lower brain stemG Kito, Y Kasé, T Miyata, et al.
European Journal of Pharmacology|June 17, 1986
The antiobesity action of (S)-(+)-1-(4-chlorophenylthiomethyl)-N-methylethylamine fumarate (AO-124)H Ikeda, K Shimakawa, G Kito, et al.
Pageof 2